Clinical Trials Support Services Market Size, Share & Trends Report

Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phase, By Service (IRB, Clinical Trial Site Management, Data Management, Patient Recruitment Management), By Sponsor, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Jul, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68039-475-9
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 110

Report Overview

The global clinical trials support services market size was valued at USD 20.03 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2021 to 2028. The global market is projected to expand rapidly due to the rising demand for trials in emerging economies, rising R&D investment, and an increasing number of Contract Research Organizations (CROs). In 2020, the COVID-19 pandemic had a solid influence on the clinical trial biological system. The pandemic has overwhelmed the medical care industry, with various associations focusing to give vaccination & medications. Every year around 900 new clinical trials are endorsed in Canada alone. A lot of clinical examinations happen in low-pay emerging nations, supported by privately-owned businesses and public foundations in developed countries.

North America clinical trials support services market size, by phase, 2018 - 2028 (USD Billion)

In addition, the pandemic is changing the method of conducting clinical trials. Administrative organizations like the European Medicines Agency (EMA), U.S. FDA, China's National Medical Products Administration, and National Institutes of Health (NIH), have given rules for conducting clinical preliminaries during the phase of COVID-19, which is in support of consolidating virtual administrations.

The pharmaceutical firms’ (R&D) venture has been steadily increasing every year, largely due to patent expirations. An ordinary patent terminates after a span of 20 years; in the pharmaceutical area, there is an arrangement provision of entry of generic version of the medication into the market following a time of 10 years. Thus, firms are boosting their R&D interest to speed the advancement of drugs, subsequently extending the whole market.

Clinical trials support services are quite useful in the event of a drug, assay design, and clinical testing. It also covers tasks, such as strengthening clinical test locations, securing and storing research medicines, drug dosage calculation, and kit handling. Preclinical groundwork and research are provided by clinical test support services, which include clinical test site assistance, obtaining and storing study drugs, blinding of study drug, patient recruiting, coordination, and reconciliation of return medications.

Phase Insights

The phase III segment dominated the global market and accounted for the largest revenue share of 53.6% in 2020. The fact that phase III studies are the most expensive and include a large number of participants drives the segment growth. As a result, demand for the phase III component rises.

The phase I segment is anticipated to register the fastest CAGR during the forecast period. Despite the tendency of outsourcing, developing nations only host a small fraction of phase I studies. As a result of the aforementioned factors, as well as rising healthcare spending, an increasing number of Investigational New Drug (IND) applications filed, and the trend of outsourcing, the drug development process is projected to drive the market.

Service Insights

The clinical trial site management segment accounted for the maximum revenue share of 43.2% in 2020 and is likely to remain dominant during the forecast years. The segment is also projected to witness the fastest CAGR of 8.7% from 2021 to 2028. Clinical trial site management services for managing offshore operations have seen tremendous expansion as a result of the trend of clinical trial outsourcing.

Proper site management by the sponsor and/or CRO is crucial for trial execution and trial success. A sufficient degree of site administration and monitoring enables facilities to efficiently recruit, treat, and retain subjects while maintaining regulatory compliance, protocol adherence, subject rights protection, subject safety, and overall management of screened and recruited subjects.

Sponsor Insights

The pharmaceutical & biopharmaceutical companies sponsor segment dominated the market with the largest revenue share of over 69% in 2020. The segment is also anticipated to witness the fastest CAGR from 2021 to 2028. This is largely attributed to the increasing R&D investments and introduction of new drugs, which have increased in the past two decades. In 2019, the pharmaceutical industry spent USD 83 billion on R&D, which is 10 times more than the amount spent in 1980.

The medical device companies segment is anticipated to show lucrative growth over the forecast period. In the clinical research industry, medical device manufacturers are minor customers, and clinical research sites generally focus on the more profitable sectors of biotechnology, pharmaceuticals, and fundamental research. However, as the FDA places an increasing focus on excellent clinical procedures, device makers will find themselves interacting with this complicated business on a far more regular basis.

Regional Insights

North America region dominated the global market in 2020 with the largest share of 50.7% as most of the pharmaceutical businesses located in the U.S. perform a majority of their business in this region. Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period. Factors driving the APAC market include a developing patient population, simplicity of administrative compliance, minimal expense of conducting studies, and the presence of a couple of top clinical organizations acting at sites.

Global clinical trials support services market share, by region, 2020 (%)

As indicated by “Novotech”, Asia Pacific’s greatest expertized biotech CRO, there is a high demand for biotechnology sponsors for studies in the APAC region because of the accessibility of value and speed. In addition, to exploit the enormous patient pool and quick track measures, a rising number of biotechnology organizations are turning to this region for their COVID-19 trials.

Key Companies & Market Share Insights

 Big firms frequently engage in mergers and acquisitions as well as new product launches to maintain their market share and increase product portfolio. For instance, in January 2020, Wuxi AppTec announced offering a fully integrated adeno-associated virus Vector Suspension Platform to accelerate cell and gene therapy development, production, and launch, therefore extending its service capabilities.

Furthermore, during the year 2020, ICON Plc gave clinical trial administrations to the Pfizer and BioNTech investigational COVID-19 program. The company worked in 153 destinations in the U.S., Latin America, Europe, and South Africa to ensure enrolment of more than 44,000 patients over a period of four months for stage 3 of the trials during the global pandemic. It is one of the largest and costliest randomized clinical trials ever performed. Some prominent players in the global clinical trials support services market include:

  • Charles River Laboratories

  • IQVIA

  • Pharmaceutical Product Development LLC

  • WuXi AppTec

  • Parexel International

  • Icon PLC

  • Laboratory Corp. of America Holdings

  • Novotech

Clinical Trials Support Services Market Report Scope

Report Attribute

Details

Market Size value in 2021

USD 21.54 billion

Revenue forecast in 2028

USD 35.2 billion

Growth rate

CAGR of 7.3% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Phase, service, sponsor, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; India; Japan; China; Thailand; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Key companies profiled

Charles River Laboratories; Insight Genetics; Eurofins Scientific SE; IQVIA; The Pharmaceutical Product Development LLC; WuXi AppTec

customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global clinical trials support services market report on the basis of phase, service, sponsor, and region:

  • Phase Outlook (Revenue, USD Million, 2016 - 2028)

    • Phase I

    • Phase II

    • Phase III

    • Phase IV

  • Service Outlook (Revenue, USD Million, 2016 - 2028)

    • Clinical trial site management

    • Patient recruitment management

    • Data management

    • Administrative staff

    • IRB

    • Others

  • Sponsor Outlook (Revenue, USD Million, 2016 - 2028)

    • Pharmaceutical & biopharmaceutical companies

    • Medical device companies

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.